Is the TNM Staging System for Breast Cancer Still Relevant in the Era of Biomarkers and Emerging Personalized Medicine for Breast Cancer – An Institution's 10‐year Experience

Publisher： John Wiley & Sons Inc

E-ISSN： 1524-4741|21|2|147-154

ISSN： 1075-122x

Source： THE BREAST JOURNAL, Vol.21, Iss.2, 2015-03, pp. : 147-154

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Personalized Therapy in Breast Cancer

By  

Oncology Research and Treatment, Vol. 35, Iss. 1, 2012-01 ,pp. : 28-33

Karger

Access to resources Recommend Favorite

Personalized medicine for breast cancer: moving forward and going back

By Ross Jeffrey S   Symmans W Fraser   Pusztai Lajos   Hortobagyi Gabriel N  

Personalized Medicine, Vol. 3, Iss. 4, 2006-11 ,pp. : 363-370

Future Medicine

Access to resources Recommend Favorite

Management of metastatic kidney cancer in the era of personalized medicine

By Monzon Jose G.   Heng Daniel Y. C.  

Critical Reviews in Clinical Laboratory Sciences, Vol. 51, Iss. 2, 2014-04 ,pp. : 85-97

Informa Healthcare

Access to resources Recommend Favorite

A national study of breast and colorectal cancer patients' decision-making for novel personalized medicine genomic diagnostics

By Issa Amalia M   Tufail Waqas   Atehortua Nelson   McKeever John  

Personalized Medicine, Vol. 10, Iss. 3, 2013-05 ,pp. : 245-256

Future Medicine

Access to resources Recommend Favorite

Breast cancer screening in an era of personalized regimens: A conceptual model and National Cancer Institute initiative for risk‐based and preference‐based approaches at a population level

By  

CANCER, Vol. 120, Iss. 19, 2014-10 ,pp. : 2955-2964

John Wiley & Sons Inc

Access to resources Recommend Favorite